CLDN1 and gastrointestinal stromal tumor: Of note, this was observed when the CLDN1 inhibitor was combined with IM, whereas no changes in the subcellular distribution of CLDN1 were detected in GIST cells treated with PDS-0330 alone (Figure 8C).